New heart device aims to fix leaky valves without open surgery
NCT ID NCT07503236
First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times
Summary
This early study tests a new device called CARLEN for people with a leaky heart valve (functional mitral regurgitation). The goal is to see if the device is safe and works well. About 30 adults with moderate-to-severe symptoms will be enrolled, and the main focus is on any serious problems within 30 days after the procedure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION FUNCTIONAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Christ Hospital
RECRUITINGCincinnati, Ohio, 45219, United States
-
University of California, Davis
RECRUITINGSacramento, California, 95616, United States
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a valve fix unlock better heart failure drugs?
- Heart valve repair may unlock better drug dosing for heart failure
- Exercise-Triggered heart valve leak targeted in new trial
- New heart valve clip aims to ease breathing and cut hospital visits
- Tiny ring could fix leaky heart valve without open surgery
- New study tests minimally invasive heart valve repair to cut hospital stays